118 related articles for article (PubMed ID: 23251908)
1. Comparison of siRNA-mediated silencing of glycosaminoglycan synthesis genes and enzyme replacement therapy for mucopolysaccharidosis in cell culture studies.
Chmielarz I; Gabig-Cimińska M; Malinowska M; Banecka-Majkutewicz Z; Węgrzyn A; Jakobkiewicz-Banecka J
Acta Biochim Pol; 2012; 59(4):697-702. PubMed ID: 23251908
[TBL] [Abstract][Full Text] [Related]
2. Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease.
Dziedzic D; Wegrzyn G; Jakóbkiewicz-Banecka J
Eur J Hum Genet; 2010 Feb; 18(2):200-5. PubMed ID: 19690584
[TBL] [Abstract][Full Text] [Related]
3. Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice.
Baldo G; Mayer FQ; Martinelli BZ; de Carvalho TG; Meyer FS; de Oliveira PG; Meurer L; Tavares A; Matte U; Giugliani R
Mol Genet Metab; 2013 May; 109(1):33-40. PubMed ID: 23562162
[TBL] [Abstract][Full Text] [Related]
4. Combined Hurler and Sanfilippo syndrome in a sibling pair.
Sun A; Hopwood JJ; Thompson J; Cederbaum SD
Mol Genet Metab; 2011 Jun; 103(2):135-7. PubMed ID: 21393040
[TBL] [Abstract][Full Text] [Related]
5. A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I.
Giugliani R; Rojas VM; Martins AM; Valadares ER; Clarke JT; Góes JE; Kakkis ED; Worden MA; Sidman M; Cox GF
Mol Genet Metab; 2009 Jan; 96(1):13-9. PubMed ID: 19038563
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).
Wraith JE; Beck M; Lane R; van der Ploeg A; Shapiro E; Xue Y; Kakkis ED; Guffon N
Pediatrics; 2007 Jul; 120(1):e37-46. PubMed ID: 17606547
[TBL] [Abstract][Full Text] [Related]
7. Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells.
Baldo G; Quoos Mayer F; Burin M; Carrillo-Farga J; Matte U; Giugliani R
Cells Tissues Organs; 2012; 195(4):323-9. PubMed ID: 21778683
[TBL] [Abstract][Full Text] [Related]
8. Effect of anti-laronidase antibodies on efficacy and safety of laronidase enzyme replacement therapy for MPS I: A comprehensive meta-analysis of pooled data from multiple studies.
Xue Y; Richards SM; Mahmood A; Cox GF
Mol Genet Metab; 2016 Apr; 117(4):419-26. PubMed ID: 26920513
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural analysis of dermal fibroblasts in mucopolysaccharidosis type I: Effects of enzyme replacement therapy and hematopoietic cell transplantation.
Cox-Brinkman J; van den Bergh Weerman MA; Wijburg FA; Aerts JM; Florquin S; van der Lee JH; Hollak CE
Ultrastruct Pathol; 2010 May; 34(3):126-32. PubMed ID: 20455661
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycosaminoglycan synthesis using rhodamine B in a mouse model of mucopolysaccharidosis type IIIA.
Roberts AL; Thomas BJ; Wilkinson AS; Fletcher JM; Byers S
Pediatr Res; 2006 Sep; 60(3):309-14. PubMed ID: 16857766
[TBL] [Abstract][Full Text] [Related]
11. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses.
Piotrowska E; Jakóbkiewicz-Banecka J; Barańska S; Tylki-Szymańska A; Czartoryska B; Wegrzyn A; Wegrzyn G
Eur J Hum Genet; 2006 Jul; 14(7):846-52. PubMed ID: 16670689
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement therapy in feline mucopolysaccharidosis I.
Kakkis ED; Schuchman E; He X; Wan Q; Kania S; Wiemelt S; Hasson CW; O'Malley T; Weil MA; Aguirre GA; Brown DE; Haskins ME
Mol Genet Metab; 2001 Mar; 72(3):199-208. PubMed ID: 11243725
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of dipeptidyl peptidase-IV (DPP-IV) activity in patients with mucopolysaccharidoses types I and II on enzyme replacement therapy - Results of a pilot study.
Hetmańczyk K; Bednarska-Makaruk M; Kierus K; Murawska-Izdebska S; Piekutowska-Abramczuk D; Pilch B; Tylki-Szymańska A; Ługowska A
Clin Biochem; 2016 Apr; 49(6):458-462. PubMed ID: 26592960
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I.
Kakkis E; McEntee M; Vogler C; Le S; Levy B; Belichenko P; Mobley W; Dickson P; Hanson S; Passage M
Mol Genet Metab; 2004; 83(1-2):163-74. PubMed ID: 15464431
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous siRNA-mediated silencing of pairs of genes coding for enzymes involved in glycosaminoglycan synthesis.
Dziedzic D; Narajczyk M; Gabig-Cimińska M; Jakóbkiewicz-Banecka J
Acta Biochim Pol; 2012; 59(2):293-8. PubMed ID: 22590693
[TBL] [Abstract][Full Text] [Related]
16. A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years.
Sifuentes M; Doroshow R; Hoft R; Mason G; Walot I; Diament M; Okazaki S; Huff K; Cox GF; Swiedler SJ; Kakkis ED
Mol Genet Metab; 2007 Feb; 90(2):171-80. PubMed ID: 17011223
[TBL] [Abstract][Full Text] [Related]
17. Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy.
Pal AR; Mercer J; Jones SA; Bruce IA; Bigger BW
PLoS One; 2018; 13(9):e0203216. PubMed ID: 30226843
[TBL] [Abstract][Full Text] [Related]
18. Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome.
Cox-Brinkman J; Boelens JJ; Wraith JE; O'meara A; Veys P; Wijburg FA; Wulffraat N; Wynn RF
Bone Marrow Transplant; 2006 Jul; 38(1):17-21. PubMed ID: 16715104
[TBL] [Abstract][Full Text] [Related]
19. Mucopolysaccharidosis type III (Sanfilippo Syndrome): emerging treatment strategies.
de Ruijter J; Valstar MJ; Wijburg FA
Curr Pharm Biotechnol; 2011 Jun; 12(6):923-30. PubMed ID: 21235449
[TBL] [Abstract][Full Text] [Related]
20. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]